The Evolution and Management of Migraine Recurrence Beyond 24 Hours

Rowan University100 enrolled

Overview

What is the course of migraine headache recurrence, how is it managed, what characteristics are associated with it, and how does it influence patient satisfaction with treatment?

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Migraine

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Female and male patients at University Headache Center with \> 6 month diagnosis of migraine with and/or without aura (ICHD-II) * Greater than or equal to 18 years old Exclusion Criteria: * Greater than 15 days/month total headache days * Analgesic use greater than 15 days/month (other than aspirin less than or equal to 325mg/d)

Locations (1)

University of Medicine and Dentistry of New Jersey

Stratford, New Jersey, United States

Outcomes

Primary Outcomes

Primary efficacy outcomes will be sustained pain free response between 4 and 72 hours after initial abortive medication dosing (lack of recurrence over 72 hours)

Time frame: 4 to 72 hours

Secondary Outcomes

Pain response and pain free data

Time frame: 30 minutes, 1,2,4,24,48,and 72 hours

Rate of recurrence, time of recurrence, time to re-dosing

Time frame: 72 hours

Rate of recurrence among multiple attacks per subject

Time frame: 72 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.